The phytochemical investigation of Pterocarpus indicus barks led to isolation of twelve compounds (1-12), including
two major triterpenoids (1 and 2), one quinone derivative (3), three phenolic compounds (4-6) and six flavonoids (7-12). A major
active compound (1) was derivatized to one new analogue (1d) and five known derivatives (1a-1c and 1e-1f). All isolated
compounds (1-12) and modified analogues (1a-1f) were evaluated for their α-glucosidase activity. In this regard, compounds 1
and 11 exhibited potent inhibitory activity towards yeast -glucosidase when compared to the positive control (acarbose). In
addition, the -glucosidase (maltase and sucrase) inhibitory activity of all compounds (1-12 and 1a-1f) was also evaluated. Only
compound 11 showed moderate inhibitory activity towards rat intestinal -glucosidase. Further study on mechanism underlying
yeast α-glucosidase inhibition indicated that 1 and 11 could retard the enzyme function by noncompetitive and mixed manners,
respectively. The experimental results were also confirmed by docking analysis. Therefore, these compounds have emerged as
promising molecules for diabetic therapy.